Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in JANX — Janux Therapeutics, Inc.

CIK 902219 Boston, MA

Position in JANX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$22,207,334
-$13,231 QoQ
Shares Held
1,597,650
-0.8% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
10 quarters on record
Voting authority Sole 0% Shared 82% None 18%

Common Shares in JANX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. JANX ranks #60 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in JANX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $22,207,334 1,597,650
2025-12-31 $22,220,565 1,610,186
2025-09-30 $17,147,198 701,604
2025-06-30 $11,373,536 492,361
2025-03-31 $10,623,879 393,477
2024-12-31 $28,665,098 535,396
2024-09-30 $658,642 14,498
2024-06-30 $1,840,395 43,934
2024-03-31 $1,189,551 31,595
2021-06-30 $228,666 9,165